Quick Approval Given COVID Vaccines Raise Concerns, Rare Disease Patients Say

Quick Approval Given COVID Vaccines Raise Concerns, Rare Disease Patients Say

292660

Quick Approval Given COVID Vaccines Raise Concerns, Rare Disease Patients Say

More than half of the people with rare diseases and their caregivers, asked in a survey, were undecided or less than willing to be vaccinated for COVID-19 if a vaccine was approved under emergency use authorization instead of the routine process, the EveryLife Foundation for Rare Disease reports. These findings highlight the need for a greater understanding of the U.S. Food and Drug Administration’s (FDA’s) emergency use authorization (EUA) process, as all current U.S. vaccines against this virus…

You must be logged in to read/download the full post.